What Researchers Did
Researchers investigated whether combining 15 hyperbaric oxygen treatments with erythropoietin could improve heart function in nine patients diagnosed with cardiac insufficiency.
What They Found
Before treatment, the average ejection fraction (EF%) of the patients was 46%. After receiving the combined therapy, the average EF% increased to 57%, showing an 11% improvement. All patients also reported feeling subjectively better and had an improved capacity for physical efforts.
What This Means for Canadian Patients
For Canadian patients with cardiac insufficiency, these findings suggest that a combination of hyperbaric oxygen therapy and erythropoietin could potentially improve heart function. This approach might lead to a measurable increase in ejection fraction and a subjective improvement in physical ability.
Canadian Relevance
No direct Canadian connection identified.
Study Limitations
This study involved a very small group of only nine patients, which limits how widely these findings can be applied.